These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7566634)

  • 1. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.
    Schiffl H
    Nephrol Dial Transplant; 1995; 10(6):911-2. PubMed ID: 7566634
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function.
    Brown PH; Kalra PA; Turney JH; Cooper EH
    Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to preserve residual renal function in patients with chronic kidney disease and on dialysis?
    Krediet RT
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii42-6. PubMed ID: 16825260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time to revisit residual renal function in haemodialysis?
    Ng TG; Johnson DW; Hawley CM
    Nephrology (Carlton); 2007 Jun; 12(3):209-17. PubMed ID: 17498114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with the artificial kidney (dialysis).
    Farrell PC; Stewart JH
    Med J Aust; 1976 Feb; 1(6):160-5. PubMed ID: 1263970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adhesion molecules in patients with chronic renal failure treated with haemodialysis].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2002 Sep; 13(75):177-81. PubMed ID: 12474564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical impact of residual function in haemodialysis.
    Carofei O; Galeotti P; Satriani M; Pedulla F; Taratufolo A
    EDTNA ERCA J; 1997; 23(3):54-6. PubMed ID: 9664012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of residual kidney function for patients on dialysis: a critical review.
    Perl J; Bargman JM
    Am J Kidney Dis; 2009 Jun; 53(6):1068-81. PubMed ID: 19394737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual renal function and recovery of renal function in patients treated by CAPD.
    Rottembourg J
    Kidney Int Suppl; 1993 Feb; 40():S106-10. PubMed ID: 8445831
    [No Abstract]   [Full Text] [Related]  

  • 12. Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis.
    Heimbürger O
    Kidney Int Suppl; 1996 Nov; 56():S47-55. PubMed ID: 8914054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising dialytic therapy.
    Rana DS; Gupta A
    J Indian Med Assoc; 2001 Apr; 99(4):222-3. PubMed ID: 11666028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?
    Van Biesen W; Lameire N; Verbeke F; Vanholder R
    J Nephrol; 2008; 21(3):299-304. PubMed ID: 18587717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
    Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
    Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-flux versus low-flux haemodialysis membranes for end-stage kidney disease.
    Nephrology (Carlton); 2013 Apr; 18(4):313-4. PubMed ID: 23530531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of dialysis membranes on lipid parameters].
    de Précigout V
    Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.